Product Information
TIMOLOL MALEATE 0.25% EYE DROP is a generic product labeled by Sandoz Inc., priced at $0.6002 per ML under NDC 61314022615. Its NADAC has been published 579 times since Nov 28, 2013.
FDA first approved this application on Apr 28, 1995. Its Orange Book therapeutic-equivalence code is AT1.
Strength
2.5 mg/mL
Manufacturer
Sandoz Inc.NDC
61314022615
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA074261FDA Approved
4/28/1995
TE Code
AT1
On Market Since
1/15/1996
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL MALEATE 0.25% EYE DROP has been published 579 times since Nov 28, 2013, and over the history we have for it it has risen 22.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6002 per ML |
|---|---|
| All-time high | $0.8404 (Jan 10, 2024) |
| All-time low | $0.3931 (May 23, 2018) |
| 52-week high | $0.6884 |
| 52-week low | $0.5490 |
| Median price | $0.5307 |
| Average price | $0.5652 |
| Largest weekly change | +40.7% (Feb 22, 2023) |
| Weeks tracked | 579 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL MALEATE 0.25% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.25% EYE DROP, manufactured by Sandoz Inc., is $0.6002 per ML (NDC 61314022615), effective Sep 30, 2026.
How has the price of TIMOLOL MALEATE 0.25% EYE DROP changed over time?
Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.25% EYE DROP has risen 22.3%. It has been tracked across 579 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.25% EYE DROP?
Since Nov 28, 2013, the NADAC for TIMOLOL MALEATE 0.25% EYE DROP has ranged from a low of $0.3931 (May 23, 2018) to a high of $0.8404 (Jan 10, 2024), with a median of $0.5307 per ML.
Are there cheaper alternatives to TIMOLOL MALEATE 0.25% EYE DROP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TIMOLOL MALEATE 0.25% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures TIMOLOL MALEATE 0.25% EYE DROP?
TIMOLOL MALEATE 0.25% EYE DROP (NDC 61314022615) is labeled by Sandoz Inc., and CMS classifies it as a generic product.